Patents Assigned to Mesa Medical, Inc.
  • Quantitation of cancer procoagulant activity in serum
    Patent number: 4784940
    Abstract: Methods and techniques are described for detecting the presence of cancer procoagulant activity in blood serum. The method provides a means of distinguishing persons or animals having cancer from those who do not have cancer. The method involves techniques for processing serum such that the activity of cancer procoagulant can be measured while the activity of other coagulation enzymes in the serum is minimized or eliminated. Then the serum can be analyzed for cancer procoagulant activity.
    Type: Grant
    Filed: June 26, 1987
    Date of Patent: November 15, 1988
    Assignee: Mesa Medical, Inc.
    Inventor: Stuart G. Gordon